BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 38067388)

  • 1. Hotspots of Somatic Genetic Variation in Pituitary Neuroendocrine Tumors.
    Torres-Morán M; Franco-Álvarez AL; Rebollar-Vega RG; Hernández-Ramírez LC
    Cancers (Basel); 2023 Dec; 15(23):. PubMed ID: 38067388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Spectrum of USP8 Pathogenic Variants in Cushing's Disease.
    Rebollar-Vega RG; Zuarth-Vázquez JM; Hernández-Ramírez LC
    Arch Med Res; 2023 Dec; 54(8):102899. PubMed ID: 37925320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Profiling of a Cohort of Italian Patients with ACTH-Secreting Pituitary Tumors and Characterization of a Novel
    Treppiedi D; Barbieri AM; Di Muro G; Marra G; Mangili F; Catalano R; Esposito E; Ferrante E; Serban AL; Locatelli M; Lania AG; Spada A; Arosio M; Peverelli E; Mantovani G
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Driver mutations in USP8 wild-type Cushing's disease.
    Sbiera S; Perez-Rivas LG; Taranets L; Weigand I; Flitsch J; Graf E; Monoranu CM; Saeger W; Hagel C; Honegger J; Assie G; Hermus AR; Stalla GK; Herterich S; Ronchi CL; Deutschbein T; Reincke M; Strom TM; Popov N; Theodoropoulou M; Fassnacht M
    Neuro Oncol; 2019 Oct; 21(10):1273-1283. PubMed ID: 31222332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. USP8, USP48, and BRAF mutations differ in their genotype-phenotype correlation in Asian Indian patients with Cushing's disease.
    Abraham AP; Pai R; Beno DL; Chacko G; Asha HS; Rajaratnam S; Kapoor N; Thomas N; Chacko AG
    Endocrine; 2022 Feb; 75(2):549-559. PubMed ID: 34664215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomics and Epigenomics of Pituitary Tumors: What Do Pathologists Need to Know?
    Asa SL; Mete O; Ezzat S
    Endocr Pathol; 2021 Mar; 32(1):3-16. PubMed ID: 33433883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The New Genetic Landscape of Cushing's Disease: Deubiquitinases in the Spotlight.
    Sbiera S; Kunz M; Weigand I; Deutschbein T; Dandekar T; Fassnacht M
    Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31717455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splicing Machinery is Dysregulated in Pituitary Neuroendocrine Tumors and is Associated with Aggressiveness Features.
    Vázquez-Borrego MC; Fuentes-Fayos AC; Venegas-Moreno E; Rivero-Cortés E; Dios E; Moreno-Moreno P; Madrazo-Atutxa A; Remón P; Solivera J; Wildemberg LE; Kasuki L; López-Fernández JM; Gadelha MR; Gálvez-Moreno MA; Soto-Moreno A; Gahete MD; Castaño JP; Luque RM
    Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31561558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Expression of Cell Cycle-Related Genes in
    Mossakowska BJ; Rusetska N; Konopinski R; Kober P; Maksymowicz M; Pekul M; Zieliński G; Styk A; Kunicki J; Bujko M
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rare Germline
    Martínez de LaPiscina I; Hernández-Ramírez LC; Portillo N; Gómez-Gila AL; Urrutia I; Martínez-Salazar R; García-Castaño A; Aguayo A; Rica I; Gaztambide S; Faucz FR; Keil MF; Lodish MB; Quezado M; Pankratz N; Chittiboina P; Lane J; Kay DM; Mills JL; Castaño L; Stratakis CA
    Front Endocrinol (Lausanne); 2020; 11():433. PubMed ID: 32714280
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and Molecular Update on Genetic Causes of Pituitary Adenomas.
    Vasilev V; Daly AF; Zacharieva S; Beckers A
    Horm Metab Res; 2020 Aug; 52(8):553-561. PubMed ID: 32299111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Gene of the Ubiquitin-Specific Protease 8 Is Frequently Mutated in Adenomas Causing Cushing's Disease.
    Perez-Rivas LG; Theodoropoulou M; Ferraù F; Nusser C; Kawaguchi K; Stratakis CA; Faucz FR; Wildemberg LE; Assié G; Beschorner R; Dimopoulou C; Buchfelder M; Popovic V; Berr CM; Tóth M; Ardisasmita AI; Honegger J; Bertherat J; Gadelha MR; Beuschlein F; Stalla G; Komada M; Korbonits M; Reincke M
    J Clin Endocrinol Metab; 2015 Jul; 100(7):E997-1004. PubMed ID: 25942478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decoding the genetic basis of Cushing's disease: USP8 in the spotlight.
    Theodoropoulou M; Reincke M; Fassnacht M; Komada M
    Eur J Endocrinol; 2015 Oct; 173(4):M73-83. PubMed ID: 26012588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multilineage Pituitary Neuroendocrine Tumors (PitNETs) Expressing PIT1 and SF1.
    Asa SL; Mete O; Riddle ND; Perry A
    Endocr Pathol; 2023 Sep; 34(3):273-278. PubMed ID: 37268858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Genetics of Pituitary Adenomas.
    Tatsi C; Stratakis CA
    J Clin Med; 2019 Dec; 9(1):. PubMed ID: 31877737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary tumours: molecular and genetic aspects.
    De Sousa SMC; Lenders NF; Lamb LS; Inder WJ; McCormack A
    J Endocrinol; 2023 Jun; 257(3):. PubMed ID: 36951812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical presentation and recurrence of pituitary neuroendocrine tumors: results from a single referral center in Colombia.
    Jimenez-Canizales CE; Rojas W; Alonso D; Romero I; Tabares S; Veronesi Zuluaga LA; Modica R; Colao A
    J Endocrinol Invest; 2023 Nov; 46(11):2275-2286. PubMed ID: 37002436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of recurrent USP48 and BRAF mutations in Cushing's disease.
    Chen J; Jian X; Deng S; Ma Z; Shou X; Shen Y; Zhang Q; Song Z; Li Z; Peng H; Peng C; Chen M; Luo C; Zhao D; Ye Z; Shen M; Zhang Y; Zhou J; Fahira A; Wang Y; Li S; Zhang Z; Ye H; Li Y; Shen J; Chen H; Tang F; Yao Z; Shi Z; Chen C; Xie L; Wang Y; Fu C; Mao Y; Zhou L; Gao D; Yan H; Zhao Y; Huang C; Shi Y
    Nat Commun; 2018 Aug; 9(1):3171. PubMed ID: 30093687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenomic and somatic mutations of pituitary tumors with clinical and pathological correlations in 111 patients.
    Guaraldi F; Morandi L; Zoli M; Mazzatenta D; Righi A; Evangelisti S; Ambrosi F; Tonon C; Giannini C; Lloyd RV; Asioli S
    Clin Endocrinol (Oxf); 2022 Dec; 97(6):763-772. PubMed ID: 36161330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription Factor ASCL1 Acts as a Novel Potential Therapeutic Target for the Treatment of the Cushing's Disease.
    Chen Z; Jia Q; Zhao Z; Zhang Q; Chen Y; Qiao N; Ye Z; Ji C; Zhang Y; He W; Shi C; Cai Y; Yao B; Han R; Wang Y; Shou X; Shen M; Cao X; Zhou X; Cheng H; Zhu J; Hu Y; Zhang Z; Ye H; Li Y; Li S; Wang Y; Ma Z; Ni T; Zhao Y
    J Clin Endocrinol Metab; 2022 Jul; 107(8):2296-2306. PubMed ID: 35521682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.